{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:57:40Z","timestamp":1791215860730,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":154,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783662451250","type":"print"},{"value":"9783662451267","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/7854_2014_299","type":"book-chapter","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T09:41:53Z","timestamp":1395394913000},"page":"191-216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Investigation of Cortisol Levels in Patients with Anxiety Disorders: A Structured Review"],"prefix":"10.1007","author":[{"given":"Hesham Yousry","family":"Elnazer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,22]]},"reference":[{"key":"299_CR1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0005-7967(89)90091-0","volume":"27","author":"JL Abelson","year":"1989","unstructured":"Abelson JL, Curtis GC (1989) Cardiac and neuroendocrine responses to exposure therapy in height phobics: desynchrony within the physiological response system. Behav Res Ther 27:561\u2013567","journal-title":"Behav Res Ther"},{"key":"299_CR2","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0006-3223(91)90330-O","volume":"29","author":"JL Abelson","year":"1991","unstructured":"Abelson JL, Nesse RM, Vinik A (1991) Stimulation of corticotropin release by pentagastrin in normal subjects and patients with panic disorder. Biol Psychiatry 29:1220\u20131223","journal-title":"Biol Psychiatry"},{"key":"299_CR3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0006-3223(94)91188-6","volume":"36","author":"JL Abelson","year":"1994","unstructured":"Abelson JL, Nesse RM, Vinik AI (1994) Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology. Biol Psychiatry 36:84\u201396","journal-title":"Biol Psychiatry"},{"key":"299_CR4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archpsyc.1996.01830040059010","volume":"53","author":"JL Abelson","year":"1996","unstructured":"Abelson JL, Curtis GC (1996a) Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol. Arch Gen Psychiatry 53:323\u2013331","journal-title":"Arch Gen Psychiatry"},{"key":"299_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1176\/ajp.153.1.69","volume":"153","author":"JL Abelson","year":"1996","unstructured":"Abelson JL, Curtis GC (1996b) Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels. Am J Psychiatry 153:69\u201373","journal-title":"Am J Psychiatry"},{"key":"299_CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-3956(95)00035-6","volume":"30","author":"JL Abelson","year":"1996","unstructured":"Abelson JL, Curtis GC, Cameron OG (1996) Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24\u00a0h secretion of adrenocorticotropin and cortisol. J Psychiatr Res 30:79\u201393","journal-title":"J Psychiatr Res"},{"key":"299_CR7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archpsyc.62.6.668","volume":"62","author":"JL Abelson","year":"2005","unstructured":"Abelson JL, Liberzon I, Young EA et al (2005) Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects. Arch Gen Psychiatry 62:668\u2013675","journal-title":"Arch Gen Psychiatry"},{"key":"299_CR8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.psy.0000242120.91030.d8","volume":"68","author":"F Ahs","year":"2006","unstructured":"Ahs F, Furmark T, Michelg\u00e5rd A et al (2006) Hypothalamic blood flow correlates positively with stress-induced cortisol levels in subjects with social anxiety disorder. Psychosom Med 68:859\u2013862","journal-title":"Psychosom Med"},{"issue":"1\u20133","key":"299_CR9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jad.2012.08.015","volume":"147","author":"CA Alfano","year":"2013","unstructured":"Alfano CA, Reynolds K, Scott N et al (2013) Polysomnographic sleep patterns of non-depressed, non-medicated children with generalized anxiety disorder. J Affect Disord 147(1\u20133):379\u2013384","journal-title":"J Affect Disord"},{"key":"299_CR10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/01.PSY.0000073872.85623.0C","volume":"65","author":"GW Alpers","year":"2003","unstructured":"Alpers GW, Abelson JL, Wilhelm FH et al (2003) Salivary cortisol response during exposure treatment in driving phobics. Psychosom Med 65:679\u2013687","journal-title":"Psychosom Med"},{"key":"299_CR11","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5). American Psychiatric Publishing, Washington","DOI":"10.1176\/appi.books.9780890425596"},{"key":"299_CR12","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/ajp.142.7.844","volume":"142","author":"DH Avery","year":"1985","unstructured":"Avery DH, Osgood TB, Ishiki DM et al (1985) The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder. Am J Psychiatry 142:844\u2013848","journal-title":"Am J Psychiatry"},{"key":"299_CR13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.euroneuro.2010.02.015","volume":"20","author":"DS Baldwin","year":"2010","unstructured":"Baldwin DS, Allgulander C, Altamura AC et al (2010) Manifesto for a european anxiety disorders research network. Eur Neuropsychopharmacol 20:426\u2013432","journal-title":"Eur Neuropsychopharmacol"},{"key":"299_CR14","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.neubiorev.2013.01.009","volume":"37","author":"DS Baldwin","year":"2013","unstructured":"Baldwin DS, Pallanti S, Zwanzger P (2013) Developing a european research network to address unmet needs in anxiety disorders. Neurosci Biobehav Rev 37:2312\u20132317","journal-title":"Neurosci Biobehav Rev"},{"key":"299_CR15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2007-979494","volume":"30","author":"B Bandelow","year":"1997","unstructured":"Bandelow B, Sengos G, Wedekind D et al (1997) Urinary excretion of cortisol, norepinephrine, testosterone, and melatonin in panic disorder. Pharmacopsychiatry 30:113\u2013117. Erratum in: Pharmacopsychiatry 1997 30, 278","journal-title":"Pharmacopsychiatry"},{"key":"299_CR16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1176\/appi.ajp.157.3.454","volume":"157","author":"B Bandelow","year":"2000","unstructured":"Bandelow B, Wedekind D, Pauls J et al (2000a) Salivary cortisol in panic attacks. Am J Psychiatry 157:454\u2013456","journal-title":"Am J Psychiatry"},{"key":"299_CR17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0165-1781(00)00183-9","volume":"95","author":"B Bandelow","year":"2000","unstructured":"Bandelow B, Wedekind D, Sandvoss V et al (2000b) Diurnal variation of cortisol in panic disorder. Psychiatry Res 95:245\u2013250","journal-title":"Psychiatry Res"},{"key":"299_CR18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/da.20062","volume":"21","author":"A Belgorodsky","year":"2005","unstructured":"Belgorodsky A, Knyazhansky L, Loewenthal U et al (2005) Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder. Depress Anxiety 21:143\u2013148. Erratum in: Depress Anxiety 2005 21:203","journal-title":"Depress Anxiety"},{"key":"299_CR20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000118890","volume":"26","author":"F Brambilla","year":"1992","unstructured":"Brambilla F, Bellodi L, Perna G et al (1992) Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiol 26:12\u201322","journal-title":"Neuropsychobiol"},{"key":"299_CR21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0306-4530(94)E0022-2","volume":"20","author":"F Brambilla","year":"1995","unstructured":"Brambilla F, Bellodi L, Arancio C et al (1995) Alpha 2-adrenergic receptor sensitivity in panic disorder: II. Cortisol response to clonidine stimulation in panic disorder. Psychoneuroendocrinol 20:11\u201319","journal-title":"Psychoneuroendocrinol"},{"key":"299_CR22","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jpsychires.2011.04.010","volume":"45","author":"S Brand","year":"2011","unstructured":"Brand S, Annen H, Holsboer-Trachsler E et al (2011) Intensive 2-day cognitive-behavioral intervention decreases cortisol secretion in soldiers suffering from specific phobia to wear protective mask. J Psychiatr Res 45:1337\u20131345","journal-title":"J Psychiatr Res"},{"issue":"8\u20139","key":"299_CR23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0006-3223(86)90254-4","volume":"21","author":"M Bridges","year":"1986","unstructured":"Bridges M, Yeragani VK, Rainey JM et al (1986) Dexamethasone suppression test in patients with panic attacks. Biol Psychiatry 21(8\u20139):853\u2013855","journal-title":"Biol Psychiatry"},{"key":"299_CR24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00004850-200015030-00004","volume":"15","author":"A Broocks","year":"2000","unstructured":"Broocks A, Bandelow B, George A et al (2000) Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder. Int Clin Psychopharmacol 15:153\u2013161","journal-title":"Int Clin Psychopharmacol"},{"key":"299_CR25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0893-133X(02)00298-1","volume":"27","author":"A Broocks","year":"2002","unstructured":"Broocks A, Bandelow B, Koch K et al (2002) Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder. Neuropsychopharmacol 27:270\u2013278","journal-title":"Neuropsychopharmacol"},{"key":"299_CR26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-977X(02)00177-3","volume":"13","author":"A Broocks","year":"2003","unstructured":"Broocks A, Meyer T, Opitz M et al (2003) 5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo. Eur Neuropsychopharmacol 13:153\u2013164","journal-title":"Eur Neuropsychopharmacol"},{"key":"299_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0006-3223(88)90121-7","volume":"24","author":"SW Carson","year":"1988","unstructured":"Carson SW, Halbreich U, Yeh CM et al (1988) Altered plasma dexamethasone and cortisol suppressibility in patients with panic disorders. Biol Psychiatry 24:56\u201362","journal-title":"Biol Psychiatry"},{"key":"299_CR28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/archpsyc.1985.01790260027003","volume":"42","author":"DS Charney","year":"1985","unstructured":"Charney DS, Heninger GR, Jatlow PI (1985) Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry 42:233\u2013243","journal-title":"Arch Gen Psychiatry"},{"key":"299_CR29","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1176\/ajp.144.8.1030","volume":"144","author":"DS Charney","year":"1987","unstructured":"Charney DS, Woods SW, Goodman WK et al (1987a) Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 144:1030\u20131036","journal-title":"Am J Psychiatry"},{"key":"299_CR30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00215473","volume":"92","author":"DS Charney","year":"1987","unstructured":"Charney DS, Woods SW, Goodman WK et al (1987b) Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacol 92:14\u201324","journal-title":"Psychopharmacol"},{"key":"299_CR31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jad.2007.07.025","volume":"106","author":"I Chaudieu","year":"2008","unstructured":"Chaudieu I, Beluche I, Norton J et al (2008) Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes. J Affect Disord 106:307\u2013313","journal-title":"J Affect Disord"},{"issue":"3B","key":"299_CR32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0002-9343(86)90330-X","volume":"80","author":"JB Cohn","year":"1986","unstructured":"Cohn JB, Wilcox CS, Meltzer HY (1986) Neuroendocrine effects of buspirone in patients with generalized anxiety disorder. Am J Med 80(3B):36\u201340","journal-title":"Am J Med"},{"key":"299_CR33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/archpsyc.1997.01830190069007","volume":"54","author":"JD Coplan","year":"1997","unstructured":"Coplan JD, Papp LA, Pine D et al (1997) Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Arch Gen Psychiatry 54:643\u2013648","journal-title":"Arch Gen Psychiatry"},{"key":"299_CR34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/archpsyc.55.2.130","volume":"55","author":"JD Coplan","year":"1998","unstructured":"Coplan JD, Goetz R, Klein DF et al (1998) Plasma cortisol concentrations preceding lactate-induced panic. Psychological, biochemical, and physiological correlates. Arch Gen Psychiatry 55:130\u2013136","journal-title":"Arch Gen Psychiatry"},{"key":"299_CR35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-1781(85)90067-8","volume":"15","author":"W Coryell","year":"1985","unstructured":"Coryell W, Noyes R Jr, Clancy J et al (1985) Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks. Psychiatry Res 15:301\u2013311","journal-title":"Psychiatry Res"},{"key":"299_CR36","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0006-3223(88)90251-X","volume":"24","author":"W Coryell","year":"1988","unstructured":"Coryell W, Noyes R (1988) HPA axis disturbance and treatment outcome in panic disorder. Biol Psychiatry 24:762\u2013766","journal-title":"Biol Psychiatry"},{"key":"299_CR37","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0006-3223(89)90287-4","volume":"25","author":"W Coryell","year":"1989","unstructured":"Coryell W, Noyes R Jr, Schlechte J (1989) The significance of HPA axis disturbance in panic disorder. Biol Psychiatry 25:989\u20131002","journal-title":"Biol Psychiatry"},{"key":"299_CR38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0006-3223(91)90038-N","volume":"29","author":"W Coryell","year":"1991","unstructured":"Coryell W, Noyes R Jr, Reich J (1991) The prognostic significance of HPA-axis disturbance in panic disorder: a 3-year follow-up. Biol Psychiatry 29:96\u2013102","journal-title":"Biol Psychiatry"},{"key":"299_CR39","first-page":"267","volume":"10","author":"J Cottraux","year":"91984","unstructured":"Cottraux J, Claustrat B 91984) The dexamethasone suppression test in agoraphobia with panic attacks. 30 cases. Encephale 10:267\u2013272 (French)","journal-title":"Encephale"},{"key":"299_CR40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-3223(95)00578-1","volume":"41","author":"GC Curtis","year":"1997","unstructured":"Curtis GC, Abelson JL, Gold PW (1997) Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment. Biol Psychiatry 41:76\u201385","journal-title":"Biol Psychiatry"},{"key":"299_CR41","doi-asserted-by":"crossref","unstructured":"Den Boer JA, Westenberg HG (1990) Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology (Berl) 102:85\u201394","DOI":"10.1007\/BF02245749"},{"key":"299_CR42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ejphar.2007.11.068","volume":"583","author":"DJ de Quervain","year":"2008","unstructured":"de Quervain DJ, Margraf J (2008) Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: a novel therapeutic approach. Eur J Pharmacol 583:365\u2013371","journal-title":"Eur J Pharmacol"},{"key":"299_CR43","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1073\/pnas.1018214108","volume":"108","author":"DJ de Quervain","year":"2011","unstructured":"de Quervain DJ, Bentz D, Michael T et al (2011) Glucocorticoids enhance extinction-based psychotherapy. Proc Natl Acad Sci USA 108:6621\u20136625","journal-title":"Proc Natl Acad Sci USA"},{"key":"299_CR44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00004850-199911000-00004","volume":"14","author":"CL DeVane","year":"1999","unstructured":"DeVane CL, Ware MR, Emmanuel NP et al (1999) Evaluation of the efficacy, safety and physiological effects of fluvoxamine in social phobia. Int Clin Psychopharmacol 14:345\u2013351","journal-title":"Int Clin Psychopharmacol"},{"key":"299_CR45","first-page":"912","volume":"82","author":"LD Dorn","year":"1997","unstructured":"Dorn LD, Burgess ES, Friedman TC et al (1997) The longitudinal course of psychopathology in Cushing\u2019s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912\u2013919","journal-title":"J Clin Endocrinol Metab"},{"key":"299_CR46","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/sj.npp.1301168","volume":"31","author":"A Erhardt","year":"2006","unstructured":"Erhardt A, Ising M, Unschuld PG et al (2006) Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacol 31:2515\u20132522","journal-title":"Neuropsychopharmacol"},{"key":"299_CR47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1176\/appi.ajp.2009.07010051","volume":"167","author":"MJ Essex","year":"2010","unstructured":"Essex MJ, Klein MH, Slattery MJ et al (2010) Early risk factors and developmental pathways to chronic high inhibition and social anxiety disorder in adolescence. Am J Psychiatry 167:40\u201346","journal-title":"Am J Psychiatry"},{"key":"299_CR48","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/0006-3223(86)90281-7","volume":"21","author":"G Faludi","year":"1986","unstructured":"Faludi G, Kask\u00f3 M, Per\u00e9nyi A et al (1986) The dexamethasone suppression test in panic disorder and major depressive episodes. Biol Psychiatry 21:1008\u20131014","journal-title":"Biol Psychiatry"},{"key":"299_CR49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0165-1781(89)90215-1","volume":"28","author":"M Fava","year":"1989","unstructured":"Fava M, Rosenbaum JF, MacLaughlin RA et al (1989) Dehydroepiandrosterone-sulfate\/cortisol ratio in panic disorder. Psychiatry Res 28:345\u2013350","journal-title":"Psychiatry Res"},{"key":"299_CR50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00006842-198507000-00001","volume":"47","author":"M Fredrikson","year":"1985","unstructured":"Fredrikson M, Sundin O, Frankenhaeuser M (1985) Cortisol excretion during the defense reaction in humans. Psychosom Med 47:313\u2013319","journal-title":"Psychosom Med"},{"key":"299_CR51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0006-3223(00)01126-4","volume":"50","author":"PM Furlan","year":"2001","unstructured":"Furlan PM, DeMartinis N, Schweizer E et al (2001) Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress. Biol Psychiatry 50:254\u2013259","journal-title":"Biol Psychiatry"},{"key":"299_CR52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.psychres.2004.04.010","volume":"133","author":"C Garcia-Leal","year":"2005","unstructured":"Garcia-Leal C, Parente AC, Del-Ben CM et al (2005) Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking. Psychiatry Res 133:239\u2013252","journal-title":"Psychiatry Res"},{"key":"299_CR53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-1781(94)90001-9","volume":"54","author":"M Germine","year":"1994","unstructured":"Germine M, Goddard AW, Sholomskas DE et al (1994) Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage. Psychiatry Res 54:115\u2013133","journal-title":"Psychiatry Res"},{"key":"299_CR54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000026677","volume":"42","author":"G Gerra","year":"2000","unstructured":"Gerra G, Zaimovic A, Zambelli U et al (2000) Neuroendocrine responses to psychological stress in adolescents with anxiety disorder. Neuropsychobiol 42:82\u201392","journal-title":"Neuropsychobiol"},{"key":"299_CR55","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1176\/ajp.144.3.408","volume":"144","author":"S Goldstein","year":"1987","unstructured":"Goldstein S, Halbreich U, Asnis G et al (1987) The hypothalamic-pituitary-adrenal system in panic disorder. Am J Psychiatry 144:1320\u20131323","journal-title":"Am J Psychiatry"},{"key":"299_CR56","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0006-3223(87)90174-0","volume":"22","author":"L Grunhaus","year":"1987","unstructured":"Grunhaus L, Tiongco D, Haskett RF et al (1987) The dexamethasone suppression test in inpatients with panic disorder or agoraphobia with panic attacks. Biol Psychiatry 22:517\u2013521","journal-title":"Biol Psychiatry"},{"key":"299_CR57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.psyneuen.2012.06.006","volume":"38","author":"K Hek","year":"2013","unstructured":"Hek K, Direk N, Newson RS et al (2013) Anxiety disorders and salivary cortisol levels in older adults: a population-based study. Psychoneuroendocrinol 38:300\u2013305","journal-title":"Psychoneuroendocrinol"},{"key":"299_CR58","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S0033291700034656","volume":"26","author":"J Herbert","year":"1996","unstructured":"Herbert J, Goodyer IM, Altham PM et al (1996) Adrenal secretion and major depression in 8\u201316-year-olds, II. Influence of co-morbidity at presentation. Psychol Med 26:257\u2013263","journal-title":"Psychol Med"},{"key":"299_CR59","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1017\/S1461145705005432","volume":"8","author":"A Herr\u00e1n","year":"2005","unstructured":"Herr\u00e1n A, Sierra-Biddle D, Garc\u00eda-Unzueta MT et al (2005) The acute phase response in panic disorder. Int J Neuropsychopharmacol 8:529\u2013535","journal-title":"Int J Neuropsychopharmacol"},{"key":"299_CR60","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0165-1781(91)90021-G","volume":"38","author":"R Hoehn-Saric","year":"1991","unstructured":"Hoehn-Saric R, McLeod DR, Lee YB et al (1991) Cortisol levels in generalized anxiety disorder. Psychiatry Res 38:313\u2013315","journal-title":"Psychiatry Res"},{"key":"299_CR61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.1989.01810020037007","volume":"46","author":"E Hollander","year":"1989","unstructured":"Hollander E, Liebowitz MR, Gorman JM et al (1989) Cortisol and sodium lactate-induced panic. Arch Gen Psychiatry 46:135\u2013140","journal-title":"Arch Gen Psychiatry"},{"key":"299_CR62","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-1781(98)00041-9","volume":"79","author":"E Hollander","year":"1998","unstructured":"Hollander E, Kwon J, Weiller F et al (1998) Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects. Psychiatry Res 79:213\u2013217","journal-title":"Psychiatry Res"},{"key":"299_CR63","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.psyneuen.2006.07.001","volume":"31","author":"SD Hood","year":"2006","unstructured":"Hood SD, Hince DA, Robinson H et al (2006) Serotonin regulation of the human stress response. Psychoneuroendocrinol 31:1087\u20131097","journal-title":"Psychoneuroendocrinol"},{"key":"299_CR65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000283560","volume":"92","author":"D Jezova","year":"2010","unstructured":"Jezova D, Vigas M, Hlavacova N et al (2010) Attenuated neuroendocrine response to hypoglycemic stress in patients with panic disorder. Neuroendocrinol 92:112\u2013119","journal-title":"Neuroendocrinol"},{"key":"299_CR66","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-2007-1017083","volume":"20","author":"FK Judd","year":"1987","unstructured":"Judd FK, Norman TR, Burrows GD et al (1987) The dexamethasone suppression test in panic disorder. Pharmacopsychiatry 20:99\u2013101","journal-title":"Pharmacopsychiatry"},{"key":"299_CR67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0278-5846(94)90064-7","volume":"18","author":"FK Judd","year":"1994","unstructured":"Judd FK, Apostolopoulos M, Burrows GD (1994) Serotonergic function in panic disorder: endocrine responses to D-fenfluramine. Prog Neuropsychopharmacol Biol Psychiatry 18:329\u2013337","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"299_CR68","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00216062","volume":"96","author":"RS Kahn","year":"1988","unstructured":"Kahn RS, Asnis GM, Wetzler S et al (1988) Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology 96:360\u2013364","journal-title":"Psychopharmacology"},{"key":"299_CR69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/da.20287","volume":"25","author":"VL Kallen","year":"2008","unstructured":"Kallen VL, Tulen JH, Utens EM et al (2008) Associations between HPA axis functioning and level of anxiety in children and adolescents with an anxiety disorder. Depress Anxiety 25:131\u2013141","journal-title":"Depress Anxiety"},{"key":"299_CR70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0165-1781(88)90064-9","volume":"24","author":"RG Kathol","year":"1988","unstructured":"Kathol RG, Noyes R Jr, Lopez AL et al (1988) Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia. Psychiatry Res 24:211\u2013221","journal-title":"Psychiatry Res"},{"key":"299_CR71","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0006-3223(89)90267-9","volume":"25","author":"RG Kathol","year":"1989","unstructured":"Kathol RG, Anton R, Noyes R et al (1989) Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder. Biol Psychiatry 25:873-878","journal-title":"Biol Psychiatry"},{"key":"299_CR72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/da.20012","volume":"20","author":"MA Katzman","year":"2004","unstructured":"Katzman MA, Koszycki D, Bradwejn J (2004) Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder. Depress Anxiety 20:51\u201358","journal-title":"Depress Anxiety"},{"key":"299_CR73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s002130050371","volume":"133","author":"M Kellner","year":"1997","unstructured":"Kellner M, Yassouridis A, Jahn H et al (1997) Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder. Psychopharmacology 133:55\u201361","journal-title":"Psychopharmacology"},{"key":"299_CR74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3956(97)00034-4","volume":"32","author":"M Kellner","year":"1998","unstructured":"Kellner M, Knaudt K, Jahn H et al (1998) Atrial natriuretic hormone in lactate-induced panic attacks: mode of release and endocrine and pathophysiological consequences. J Psychiatr Res 32:37\u201348","journal-title":"J Psychiatr Res"},{"key":"299_CR75","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2004.08.005","volume":"56","author":"M Kellner","year":"2004","unstructured":"Kellner M, Schick M, Yassouridis A et al (2004) Metyrapone tests in patients with panic disorder. Biol Psychiatry 56:898\u2013900","journal-title":"Biol Psychiatry"},{"key":"299_CR76","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1600-0447.1995.tb09604.x","volume":"92","author":"E Klein","year":"1995","unstructured":"Klein E, Zinder O, Colin V et al (1995) Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder. Acta Psychiatr Scand 92:399\u2013408","journal-title":"Acta Psychiatr Scand"},{"key":"299_CR77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10615800802169358","volume":"22","author":"K Knopf","year":"2009","unstructured":"Knopf K, P\u00f6ssel P (2009) Individual response differences in spider phobia: comparing phobic and non-phobic women of different reactivity levels. Anxiety Stress Coping 22:39\u201355","journal-title":"Anxiety Stress Coping"},{"key":"299_CR78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10802-011-9548-9","volume":"40","author":"M Kr\u00e4mer","year":"2012","unstructured":"Kr\u00e4mer M, Seefeldt WL, Heinrichs N et al (2012) Subjective, autonomic, and endocrine reactivity during social stress in children with social phobia. J Abnorm Child Psychol 40:95\u2013104","journal-title":"J Abnorm Child Psychol"},{"key":"299_CR79","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1017\/S1461145710000581","volume":"13","author":"R Lanzenberger","year":"2010","unstructured":"Lanzenberger R, Wadsak W, Spindelegger C et al (2010) Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions. Int J Neuropsychopharmacol 13:1129\u20131143","journal-title":"Int J Neuropsychopharmacol"},{"key":"299_CR80","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.psychres.2005.07.003","volume":"137","author":"N Laufer","year":"2005","unstructured":"Laufer N, Maayan R, Hermesh H et al (2005) Involvement of GABAA receptor modulating neuroactive steroids in patients with social phobia. Psychiatry Res 137:131\u2013136. Erratum in: Psychiatry Res 144:95","journal-title":"Psychiatry Res"},{"key":"299_CR81","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/JGP.0b013e3181ec806c","volume":"19","author":"EJ Lenze","year":"2011","unstructured":"Lenze EJ, Mantella RC, Shi P et al (2011) Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram. Am J Geriatr Psychiatry 19:482\u2013490","journal-title":"Am J Geriatr Psychiatry"},{"key":"299_CR82","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/gps.2732","volume":"27","author":"EJ Lenze","year":"2012","unstructured":"Lenze EJ, Dixon D, Mantella RC et al (2012) Treatment-related alteration of cortisol predicts change in neuropsychological function during acute treatment of late-life anxiety disorder. Int J Geriatr Psychiatry 27:454\u2013462","journal-title":"Int J Geriatr Psychiatry"},{"key":"299_CR83","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF02253597","volume":"106","author":"KP Lesch","year":"1992","unstructured":"Lesch KP, Wiesmann M, Hoh A et al (1992) 5-HT1A receptor-effector system responsivity in panic disorder. Psychopharmacology 106:111\u2013117","journal-title":"Psychopharmacology"},{"key":"299_CR84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-1781(87)90058-8","volume":"21","author":"AP Levin","year":"1987","unstructured":"Levin AP, Doran AR, Liebowitz MR et al (1987) Pituitary adrenocortical unresponsiveness in lactate-induced panic. Psychiatry Res 21:23\u201332","journal-title":"Psychiatry Res"},{"key":"299_CR85","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1176\/ajp.140.7.917","volume":"140","author":"JA Lieberman","year":"1983","unstructured":"Lieberman JA, Brenner R, Lesser M et al (1983) Dexamethasone suppression tests in patients with panic disorder. Am J Psychiatry 140:917\u2013919","journal-title":"Am J Psychiatry"},{"key":"299_CR86","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archpsyc.1985.01790300077010","volume":"42","author":"MR Liebowitz","year":"1985","unstructured":"Liebowitz MR, Gorman JM, Fyer AJ et al (1985) Lactate provocation of panic attacks. II. Biochemical and physiological findings. Arch Gen Psychiatry 42:709\u2013719","journal-title":"Arch Gen Psychiatry"},{"key":"299_CR87","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00737-011-0234-2","volume":"14","author":"C Lilliecreutz","year":"2011","unstructured":"Lilliecreutz C, Theodorsson E, Sydsj\u00f6 G et al (2011) Salivary cortisol in pregnant women suffering from blood and injection phobia. Arch Womens Ment Health 14:405\u2013411","journal-title":"Arch Womens Ment Health"},{"key":"299_CR88","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0306-4530(90)90043-9","volume":"15","author":"AL Lopez","year":"1990","unstructured":"Lopez AL, Kathol RG, Noyes R Jr (1990) Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder. Psychoneuroendocrinol 15:23\u201328","journal-title":"Psychoneuroendocrinol"},{"key":"299_CR89","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-2007-1014405","volume":"25","author":"PT Loosen","year":"1992","unstructured":"Loosen PT, Chambliss B, DeBold CR et al (1992) Psychiatric phenomenology in Cushing\u2019s disease. Pharmacopsychiatry 25:192\u2013198","journal-title":"Pharmacopsychiatry"},{"key":"299_CR90","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-1781(91)90020-P","volume":"38","author":"RJ Maddock","year":"1991","unstructured":"Maddock RJ, Carter CS, Gietzen DW (1991) Elevated serum lactate associated with panic attacks induced by hyperventilation. Psychiatry Res 38:301\u2013311","journal-title":"Psychiatry Res"},{"key":"299_CR91","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/(SICI)1520-6394(1999)10:1<25::AID-DA4>3.0.CO;2-O","volume":"10","author":"FL Martel","year":"1999","unstructured":"Martel FL, Hayward C, Lyons DM et al (1999) Salivary cortisol levels in socially phobic adolescent girls. Depress Anxiety 10:25\u201327","journal-title":"Depress Anxiety"},{"key":"299_CR92","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archpsyc.1984.01790190045005","volume":"41","author":"RM Nesse","year":"1984","unstructured":"Nesse RM, Cameron OG, Curtis GC et al (1984) Adrenergic function in patients with panic anxiety. Arch Gen Psychiatry 41:771\u2013776","journal-title":"Arch Gen Psychiatry"},{"key":"299_CR93","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00006842-198507000-00002","volume":"47","author":"RM Nesse","year":"1985","unstructured":"Nesse RM, Curtis GC, Thyer BA et al (1985) Endocrine and cardiovascular responses during phobic anxiety. Psychosom Med 47:320\u2013332","journal-title":"Psychosom Med"},{"key":"299_CR94","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1749-6632.2009.04978.x","volume":"1179","author":"CM Pariante","year":"2009","unstructured":"Pariante CM (2009) Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressants and glucocorticoids. Ann NY Acad Sci 1179:144\u2013152","journal-title":"Ann NY Acad Sci"},{"key":"299_CR95","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0006-3223(98)00053-5","volume":"44","author":"ER Peskind","year":"1998","unstructured":"Peskind ER, Jensen CF, Pascualy M et al (1998) Sodium lactate and hypertonic sodium chloride induce equivalent panic incidence, panic symptoms, and hypernatremia in panic disorder. Biol Psychiatry 44:1007\u20131016","journal-title":"Biol Psychiatry"},{"key":"299_CR96","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00004714-198504000-00008","volume":"5","author":"GA Peterson","year":"1985","unstructured":"Peterson GA, Ballenger JC, Cox DP et al (1985) The dexamethasone suppression test in agoraphobia. J Clin Psychopharmacol 5:100\u2013102","journal-title":"J Clin Psychopharmacol"},{"key":"299_CR97","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.psyneuen.2009.08.003","volume":"35","author":"K Petrowski","year":"2010","unstructured":"Petrowski K, Herold U, Joraschky P et al (2010) A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses. Psychoneuroendocrinol 35:414\u2013421","journal-title":"Psychoneuroendocrinol"},{"key":"299_CR98","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.psyneuen.2011.12.013","volume":"37","author":"K Petrowski","year":"2012","unstructured":"Petrowski K, Wintermann GB, Kirschbaum C et al (2012) Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder. Psychoneuroendocrinol 37:1199\u20131208","journal-title":"Psychoneuroendocrinol"},{"key":"299_CR99","doi-asserted-by":"publisher","unstructured":"Petrowski K, Wintermann GB, Schaarschmidt M et al (2013) Blunted salivary and plasma cortisol response in patients with panic disorder under psychosocial stress. Int J Psychophysiol doi:pii: S0167\u20138760(13):00017\u20132. 10.1016\/j.ijpsycho.2013.01.002. (Epub ahead of print)","DOI":"10.1016\/j.ijpsycho.2013.01.002"},{"key":"299_CR100","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.psyneuen.2010.09.011","volume":"36","author":"AC Phillips","year":"2011","unstructured":"Phillips AC, Batty GD, Gale CR et al (2011) Major depressive disorder, generalised anxiety disorder, and their comorbidity: associations with cortisol in the vietnam experience study. Psychoneuroendocrinol 36:682\u2013690","journal-title":"Psychoneuroendocrinol"},{"key":"299_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-004-1974-8","volume":"178","author":"N Pomara","year":"2005","unstructured":"Pomara N, Willoughby LM, Sidtis JJ et al (2005) Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder. Psychopharmacol (Berl) 178:1\u20138","journal-title":"Psychopharmacol (Berl)"},{"issue":"Suppl","key":"299_CR102","first-page":"41","volume":"52","author":"NL Potts","year":"1991","unstructured":"Potts NL, Davidson JR, Krishnan KR et al (1991) Levels of urinary free cortisol in social phobia. J Clin Psychiatry 52(Suppl):41\u201342","journal-title":"J Clin Psychiatry"},{"key":"299_CR103","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0006-3223(91)90135-9","volume":"29","author":"MH Rapaport","year":"1991","unstructured":"Rapaport MH, Risch SC, Gillin JC et al (1991) The effects of physostigmine infusion on patients with panic disorder. Biol Psychiatry 29:658\u2013664","journal-title":"Biol Psychiatry"},{"key":"299_CR105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.biopsych.2008.08.022","volume":"65","author":"K Roelofs","year":"2009","unstructured":"Roelofs K, van Peer J, Berretty E et al (2009) Hypothalamus-pituitary-adrenal axis hyperresponsiveness is associated with increased social avoidance behavior in social phobia. Biol Psychiatry 65:336\u2013343","journal-title":"Biol Psychiatry"},{"key":"299_CR106","first-page":"432","volume":"17","author":"CB Rosnick","year":"2013","unstructured":"Rosnick CB, Rawson KS, Butters MA et al (2013) Association of cortisol with neuropsychological assessment in older adults with generalized anxiety disorder 17:432\u2013440","journal-title":"Association of cortisol with neuropsychological assessment in older adults with generalized anxiety disorder"},{"key":"299_CR107","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1176\/ajp.143.7.896","volume":"143","author":"PP Roy-Byrne","year":"1986","unstructured":"Roy-Byrne PP, Uhde TW, Post RM et al (1986) The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 143:896\u2013899","journal-title":"Am J Psychiatry"},{"key":"299_CR108","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-3223(91)90072-T","volume":"30","author":"PP Roy-Byrne","year":"1991","unstructured":"Roy-Byrne PP, Cowley DS, Hommer D et al (1991) Neuroendocrine effects of diazepam in panic and generalized anxiety disorders. Biol Psychiatry 30:73\u201380","journal-title":"Biol Psychiatry"},{"key":"299_CR157","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0278-5846(96)00102-9","volume":"20","author":"I Sasaki","year":"1996","unstructured":"Sasaki I, Akiyoshi J, Sakurai R, et al (1996) Carbon dioxide induced panic attack in panic disorder in Japan. Prog Neuropsychopharmacol Biol Psychiatry 20:1145\u20131157","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6 Pt 2","key":"299_CR109","first-page":"H2630","volume":"272","author":"FE Seier","year":"1997","unstructured":"Seier FE, Kellner M, Yassouridis A et al (1997) Autonomic reactivity and hormonal secretion in lactate-induced panic attacks. Am J Physiol 272(6 Pt 2):H2630\u2013H2638","journal-title":"Am J Physiol"},{"key":"299_CR110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0165-0327(94)00059-I","volume":"33","author":"M Schittecatte","year":"1995","unstructured":"Schittecatte M, Garcia-Valentin J, Charles G et al (1995) Efficacy of the clonidine REM suppression test (CREST) to separate patients with major depression from controls; a comparison with three currently proposed biological markers of depression. J Affect Disord 33:151\u2013157","journal-title":"J Affect Disord"},{"key":"299_CR111","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-002-1072-8","volume":"161","author":"K Schruers","year":"2002","unstructured":"Schruers K, van Diest R, Nicolson N et al (2002) L-5-hydroxytryptophan induced increase in salivary cortisol in panic disorder patients and healthy volunteers. Psychopharmacology 161:365\u2013369","journal-title":"Psychopharmacology"},{"key":"299_CR112","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1192\/bjp.149.3.320","volume":"149","author":"EE Schweizer","year":"1986","unstructured":"Schweizer EE, Swenson CM, Winokur A et al (1986) The dexamethasone suppression test in generalised anxiety disorder. Br J Psychiatry 149:320\u2013322","journal-title":"Br J Psychiatry"},{"key":"299_CR113","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0269881110364270","volume":"25","author":"K Seddon","year":"2011","unstructured":"Seddon K, Morris K, Bailey J et al (2011) Effects of 7.5\u00a0% CO2 challenge in generalized anxiety disorder. J Psychopharmacol 25:43\u201351","journal-title":"J Psychopharmacol"},{"key":"299_CR114","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1176\/ajp.140.8.1063","volume":"140","author":"DV Sheehan","year":"1983","unstructured":"Sheehan DV, Claycomb JB, Surman OS et al (1983) Panic attacks and the dexamethasone suppression test. Am J Psychiatry 140:1063\u20131064","journal-title":"Am J Psychiatry"},{"key":"299_CR115","first-page":"332","volume":"22","author":"J Shlik","year":"1997","unstructured":"Shlik J, Aluoja A, Vasar V et al (1997) Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. J Psychiatry Neurosci 22:332\u2013340","journal-title":"J Psychiatry Neurosci"},{"key":"299_CR116","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S146114570300405X","volume":"7","author":"J Shlik","year":"2004","unstructured":"Shlik J, Maron E, Tru I et al (2004) Citalopram challenge in social anxiety disorder. Int J Neuropsychopharmacol 7:177\u2013182","journal-title":"Int J Neuropsychopharmacol"},{"key":"299_CR117","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-1781(99)00029-3","volume":"86","author":"SS Sinha","year":"1999","unstructured":"Sinha SS, Coplan JD, Pine DS et al (1999) Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation. Psychiatry Res 86:93\u201398","journal-title":"Psychiatry Res"},{"key":"299_CR118","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jpsychires.2010.07.002","volume":"45","author":"A Siegmund","year":"2011","unstructured":"Siegmund A, K\u00f6ster L, Meves AM et al (2011) Stress hormones during flooding therapy and their relationship to therapy outcome in patients with panic disorder and agoraphobia. J Psychiatr Res 45:339\u2013346","journal-title":"J Psychiatr Res"},{"key":"299_CR119","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1073\/pnas.0509184103","volume":"103","author":"LM Soravia","year":"2006","unstructured":"Soravia LM, Heinrichs M, Aerni A et al (2006) Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci U S A 103:5585\u20135590","journal-title":"Proc Natl Acad Sci U S A"},{"key":"299_CR120","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.psyneuen.2012.11.015","volume":"38","author":"SM Staufenbiel","year":"2013","unstructured":"Staufenbiel SM, Penninx BW, Spijker AT et al (2013) Hair cortisol, stress exposure, and mental health in humans: a systematic review. Psychoneuroendocrinol 38:1220\u20131235","journal-title":"Psychoneuroendocrinol"},{"key":"299_CR121","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0006-3223(88)90201-6","volume":"24","author":"MB Stein","year":"1988","unstructured":"Stein MB, Uhde TW (1988) Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls. Biol Psychiatry 24:322\u2013330","journal-title":"Biol Psychiatry"},{"issue":"2\u20133","key":"299_CR122","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.psychres.2010.09.002","volume":"186","author":"S Steudte","year":"2011","unstructured":"Steudte S, Stalder T, Dettenborn L et al (2011) Decreased hair cortisol concentrations in generalised anxiety disorder. Psychiatry Res 186(2\u20133):310\u2013314","journal-title":"Psychiatry Res"},{"issue":"1\u20133","key":"299_CR123","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0165-0327(98)00058-5","volume":"52","author":"A Stones","year":"1999","unstructured":"Stones A, Groome D, Perry D et al (1999) The effect of stress on salivary cortisol in panic disorder patients. J Affect Disord 52(1\u20133):197\u2013201","journal-title":"J Affect Disord"},{"key":"299_CR124","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1176\/ajp.155.5.610","volume":"155","author":"A Str\u00f6hle","year":"1998","unstructured":"Str\u00f6hle A, Kellner M, Yassouridis A et al (1998) Effect of flumazenil in lactate-sensitive patients with panic disorder. Am J Psychiatry 155:610\u2013612","journal-title":"Am J Psychiatry"},{"key":"299_CR125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0893-133X(99)00115-3","volume":"22","author":"A Str\u00f6hle","year":"2000","unstructured":"Str\u00f6hle A, Holsboer F, Rupprecht R (2000) Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder. Neuropsychopharmacol 22:251\u2013256","journal-title":"Neuropsychopharmacol"},{"key":"299_CR126","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3758\/CABN.1.4.388","volume":"1","author":"GE Tafet","year":"2001","unstructured":"Tafet GE, Idoyaga-Vargas VP, Abulafia DP et al (2001) Correlation between cortisol level and serotonin uptake in patients with chronic stress and depression. Cogn Affect Behav Neurosci 1:388\u2013393","journal-title":"Cogn Affect Behav Neurosci"},{"key":"299_CR127","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3758\/CABN.5.1.37","volume":"5","author":"GE Tafet","year":"2005","unstructured":"Tafet GE, Feder DJ, Abulafia DP et al (2005) Regulation of hypothalamic-pituitary-adrenal activity in response to cognitive therapy in patients with generalized anxiety disorder. Cogn Affect Behav Neurosci 5:37\u201340","journal-title":"Cogn Affect Behav Neurosci"},{"key":"299_CR128","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/anxi.3070010307","volume":"1","author":"ME Tancer","year":"1994","unstructured":"Tancer ME, Mailman RB, Stein MB et al (1994\u20131995) Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia. Anxiety 1:216\u2013223","journal-title":"Anxiety"},{"key":"299_CR129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0165-1781(89)90210-2","volume":"28","author":"SD Targum","year":"1989","unstructured":"Targum SD, Marshall LE (1989) Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res 28:295\u2013306","journal-title":"Psychiatry Res"},{"key":"299_CR130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0006-3223(90)90428-5","volume":"28","author":"SD Targum","year":"1990","unstructured":"Targum SD (1990) Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder. Biol Psychiatry 28:21\u201334","journal-title":"Biol Psychiatry"},{"key":"299_CR131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-3223(88)90037-6","volume":"23","author":"JW Tiller","year":"1988","unstructured":"Tiller JW, Biddle N, Maguire KP et al (1988) The dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder. Biol Psychiatry 23:261\u2013270","journal-title":"Biol Psychiatry"},{"key":"299_CR132","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0006-3223(88)90004-2","volume":"23","author":"TW Uhde","year":"1988","unstructured":"Uhde TW, Joffe RT, Jimerson DC et al (1988) Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biol Psychiatry 23:575\u2013585","journal-title":"Biol Psychiatry"},{"key":"299_CR133","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0165-0327(94)90076-0","volume":"30","author":"TW Uhde","year":"1994","unstructured":"Uhde TW, Tancer ME, Gelernter CS et al (1994) Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers. J Affect Disord 30:155\u2013161","journal-title":"J Affect Disord"},{"key":"299_CR134","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.euroneuro.2004.01.001","volume":"14","author":"NJ van der Wee","year":"2004","unstructured":"van der Wee NJ, Fiselier J, van Megen HJ et al (2004) Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls. Eur Neuropsychopharmacol 14:413\u2013417","journal-title":"Eur Neuropsychopharmacol"},{"key":"299_CR135","first-page":"386","volume":"25","author":"MA van Duinen","year":"2004","unstructured":"van Duinen MA, Schruers KR, Jaegers E et al (2004) Salivary cortisol in panic: are males more vulnerable? Neuro Endocrinol Lett 25:386\u2013390","journal-title":"Neuro Endocrinol Lett"},{"key":"299_CR136","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/0269881105051527","volume":"19","author":"MA van Duinen","year":"2005","unstructured":"van Duinen MA, Schruers KR, Maes M et al (2005) CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers. J Psychopharmacol 19:243\u2013247","journal-title":"J Psychopharmacol"},{"key":"299_CR137","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1017\/S1461145706007358","volume":"10","author":"MA van Duinen","year":"2007","unstructured":"van Duinen MA, Schruers KR, Maes M et al (2007) CO2 challenge induced HPA axis activation in panic. Int J Neuropsychopharmacol 10:797\u2013804","journal-title":"Int J Neuropsychopharmacol"},{"key":"299_CR138","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/0269881108098821","volume":"24","author":"MA van Duinen","year":"2010","unstructured":"van Duinen MA, Schruers KR, Griez EJ (2010) Desynchrony of fear in phobic exposure. J Psychopharmacol 24:695\u2013699","journal-title":"J Psychopharmacol"},{"key":"299_CR139","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0924-977X(96)00018-1","volume":"6","author":"HJ van Megen","year":"1996","unstructured":"van Megen HJ, Westenberg HG, Den Boer JA et al (1996) The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder. Eur Neuropsychopharmacol 6:187\u2013194","journal-title":"Eur Neuropsychopharmacol"},{"key":"299_CR140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biopsycho.2009.03.006","volume":"81","author":"JM van Peer","year":"2009","unstructured":"van Peer JM, Spinhoven P, van Dijk JG et al (2009) Cortisol-induced enhancement of emotional face processing in social phobia depends on symptom severity and motivational context. Biol Psychol 81:123\u2013130","journal-title":"Biol Psychol"},{"key":"299_CR141","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.euroneuro.2007.03.005","volume":"17","author":"JF Van Veen","year":"2007","unstructured":"Van Veen JF, Van der Wee NJ, Fiselier J et al (2007) Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls. Eur Neuropsychopharmacol 17:637\u2013642","journal-title":"Eur Neuropsychopharmacol"},{"key":"299_CR142","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.psyneuen.2009.09.012","volume":"35","author":"JM van Peer","year":"2010","unstructured":"van Peer JM, Spinhoven P, Roelofs K (2010) Psychophysiological evidence for cortisol-induced reduction in early bias for implicit social threat in social phobia. Psychoneuroendocrinol 35:21\u201332","journal-title":"Psychoneuroendocrinol"},{"key":"299_CR143","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.psyneuen.2008.07.004","volume":"33","author":"JF van Veen","year":"2008","unstructured":"van Veen JF, van Vliet IM, Derijk RH et al (2008) Elevated alpha-amylase but not cortisol in generalized social anxiety disorder. Psychoneuroendocrinol 33:1313\u20131321","journal-title":"Psychoneuroendocrinol"},{"key":"299_CR144","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.psyneuen.2009.05.007","volume":"34","author":"JF van Veen","year":"2009","unstructured":"van Veen JF, van Vliet IM, de Rijk RH et al (2009) Tryptophan depletion affects the autonomic stress response in generalized social anxiety disorder. Psychoneuroendocrinol 34:1590\u20131594","journal-title":"Psychoneuroendocrinol"},{"key":"299_CR145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0924-977X(95)00070-6","volume":"6","author":"IM van Vliet","year":"1996","unstructured":"van Vliet IM, Slaap BR, Westenberg HG et al (1996) Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder. Eur Neuropsychopharmacol 6:103\u2013110","journal-title":"Eur Neuropsychopharmacol"},{"key":"299_CR146","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jad.2008.03.006","volume":"111","author":"D van West","year":"2008","unstructured":"van West D, Claes S, Sulon J et al (2008) Hypothalamic-pituitary-adrenal reactivity in prepubertal children with social phobia. J Affect Disord 111:281\u2013290","journal-title":"J Affect Disord"},{"key":"299_CR147","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0165-1781(87)90015-1","volume":"21","author":"EC Villacres","year":"1987","unstructured":"Villacres EC, Hollifield M, Katon WJ et al (1987) Sympathetic nervous system activity in panic disorder. Psychiatry Res 21:313\u2013321","journal-title":"Psychiatry Res"},{"key":"299_CR148","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/PSY.0b013e3181d2f0c8","volume":"72","author":"SA Vreeburg","year":"2010","unstructured":"Vreeburg SA, Zitman FG, van Pelt J et al (2010) Salivary cortisol levels in persons with and without different anxiety disorders. Psychosom Med 72:340\u2013347","journal-title":"Psychosom Med"},{"key":"299_CR149","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s007020070062","volume":"107","author":"D Wedekind","year":"2000","unstructured":"Wedekind D, Bandelow B, Broocks A et al (2000) Salivary, total plasma and plasma free cortisol in panic disorder. J Neural Trans 107:831\u2013837","journal-title":"J Neural Trans"},{"key":"299_CR150","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.2174\/138161208786848757","volume":"14","author":"D Wedekind","year":"2008","unstructured":"Wedekind D, Sprute A, Broocks A et al (2008) Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorder. Curr Pharm Des 14:3518\u20133524","journal-title":"Curr Pharm Des"},{"key":"299_CR151","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0006-3223(91)90109-Y","volume":"30","author":"P Westberg","year":"1991","unstructured":"Westberg P, Modigh K, Lisj\u00f6 P et al (1991) Higher postdexamethasone serum cortisol levels in agoraphobic than in nonagoraphobic panic disorder patients. Biol Psychiatry 30:247\u2013256","journal-title":"Biol Psychiatry"},{"key":"299_CR152","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-1781(96)02001-X","volume":"64","author":"S Wetzler","year":"1996","unstructured":"Wetzler S, Asnis GM, DeLecuona JM et al (1996) Serotonin function in panic disorder: intravenous administration of meta-chlorophenylpiperazine. Psychiatry Res 64:77\u201382","journal-title":"Psychiatry Res"},{"key":"299_CR153","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00444706","volume":"98","author":"HG Westenberg","year":"1989","unstructured":"Westenberg HG, den Boer JA (1989) Serotonin function in panic disorder: effect of 1-5-hydroxytryptophan in patients and controls. Psychopharmacology 98:283\u2013285","journal-title":"Psychopharmacology"},{"key":"299_CR154","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3109\/00048678409158800","volume":"18","author":"HA Whiteford","year":"1984","unstructured":"Whiteford HA, Evans L (1984) Agoraphobia and the dexamethasone suppression test: atypical depression? Aust N Z J Psychiatry 18:374\u2013377","journal-title":"Aust N Z J Psychiatry"},{"key":"299_CR155","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archpsyc.58.4.371","volume":"58","author":"K Wiedemann","year":"2001","unstructured":"Wiedemann K, Jahn H, Yassouridis A et al (2001) Anxiolytic-like effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings. Arch Gen Psychiatry 58:371\u2013377","journal-title":"Arch Gen Psychiatry"},{"key":"299_CR156","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archpsyc.1987.01800160077010","volume":"44","author":"SW Woods","year":"1987","unstructured":"Woods SW, Charney DS, McPherson CA et al (1987) Situational panic attacks. Behavioral, physiologic, and biochemical characterization. Arch Gen Psychiatry 44:365\u2013375","journal-title":"Arch Gen Psychiatry"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Neurobiology of Stress-related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2014_299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T15:24:06Z","timestamp":1676561046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2014_299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783662451250","9783662451267"],"references-count":154,"URL":"https:\/\/doi.org\/10.1007\/7854_2014_299","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"22 March 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}